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Montmorency tart cherries (Prunus cerasus L.) are rich in anthocyanins, compounds capable of augmenting fat 
oxidation and regulating metabolic dysfunction. The present study examined whether Montmorency tart cherry juice 
(MTCJ) supplementation could augment fat oxidation rates at rest and during FATMAX exercise, thus improve 
cardio-metabolic health. Eleven, healthy participants consumed MTCJ or placebo (PLA) twice daily, in a 
randomised, counterbalanced order for 20 days. Participants cycled at FATMAX for 1-hour pre-, mid- (10 days) and 
post-supplementation whilst substrate oxidation rates were measured. Before exercise anthropometrics and resting 
metabolic rate were measured. Blood pressure, serum triglycerides, cholesterol, HDL, total antioxidant status (TAS) 
and glucose were measured immediately before and after exercise. No significant differences between conditions or 
interactions were observed for any functional and blood-based cardio-metabolic markers or fat oxidation during 
exercise or rest (P > 0.05). Pre-exercise TAS (P = 0.036) and HDL (P = 0.001) were significantly reduced from mid- 
to post-supplementation with MTCJ only. Twenty days MTCJ supplementation had no effect on fat oxidation, 
therefore it is unnecessary for individuals in this participant cohort to consume MTCJ with exercise to improve 
cardio-metabolic biomarkers. 
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Introduction 
Cardiovascular disease, type 2 diabetes mellitus and associated diseases combined are the leading health burden and 
cause of mortality worldwide (Guo & Ling, 2015), therefore the necessity for an intervention is paramount. Dietary 
interventions to improve cardio-metabolic health are highly sought after as they possess less risk than 
pharmacological drugs (Vendrame, Del Bo, Ciappellano, Riso, & Klimis-Zacas, 2016). Substantial evidence now 
exists demonstrating the relationship between high consumption of vegetables and fruits, improvements in disease 
symptoms and the reduced risk of disease development  (Li, Wang, Luo, Zhao, & Chen, 2017). However, concerns 
remain over the feasibility of maintaining a high fruit and vegetable intake over a prolonged time period, therefore 
daily dietary supplementation containing health-promoting phytonutrients is appealing. Subsequently, the present 
study supplemented small volumes of highly concentrated Montmorency tart cherry juice (MTCJ), to boost 
consumption of anthocyanins and thus provide sufficient amounts at physiologically relevant concentrations in a 
more practical and efficient method (Zheng et al., 2017).  
Anthocyanins, a major polyphenolic sub-class of flavonoids, are predominantly responsible for the dark red, blue, 
black and purple pigments found in various fruits and vegetables (Wu et al., 2006). Anthocyanins are powerful 
antioxidants also capable of ameliorating cardio-metabolic dysfunction (He & Giusti, 2010). A recent 
epidemiological study highlighted a significant correlation with anthocyanin consumption and improved long-term 
weight management (Bertoia et al., 2016). Tart cherries (Prunus cerasus L.) and thus tart cherry juice possess a high 
phytochemical content particularly rich in specific anthocyanins, flavonols and phenolic acids (Kirakosyan, 
Seymour, Llanes, Kaufman, & Bolling, 2009; Kirakosyan et al., 2010).  These phytochemicals are thought to 
contribute to effectively combating oxidative stress, inflammation and repairing muscle damage post-exercise (Bell, 
Walshe, Davison, Stevenson, & Howatson, 2014b; Bell, Walshe, Davison, Stevenson, & Howatson, 2015). In 
rodents, tart cherries have shown significant improvements at the molecular, cellular and systemic level 
predominantly due to modulation of peroxisome proliferator-activated receptor (PPAR) signalling pathways 
(Seymour et al., 2009; Seymour et al., 2008). Consequently, percentage fat mass, hyperinsulinaemia, 
hyperlipidaemia and inflammation were all reduced (Seymour et al., 2009; Seymour et al., 2008). Observations in 
humans have been more equivocal, with tart cherry supplementation showing no effect on blood pressure and blood-
based cardio-metabolic markers in healthy participants (Lynn et al., 2014). More favourable findings have been 
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reported in studies (Ataie-Jafari, Hosseini, Karimi, & Pajouhi, 2008; Keane et al., 2016a; Keane, Haskell-Ramsay, 
Veasey, & Howatson, 2016b; Martin, Bopp, Neupane, & Vega-Lopez, 2010) examining ‘at risk’ or diseased patients 
with tart cherry juice, indicating amelioration of cardio-metabolic function. 
Skeletal muscle is a critical organ involved in lipid metabolism and dysfunction of cellular and molecular cascades 
which are implicated in the manifestation of cardiovascular disease, insulin resistance, inflammation and oxidative 
stress (Stump, Henriksen, Wei, & Sowers, 2006). During sub-maximal exercise at FATMAX intensities [intensity 
eliciting maximal fat oxidation rate, conveyed as percentage of maximal oxygen uptake (%V̇O2max)], the primary 
source of energy is derived from oxidation of free fatty acids and intramuscular triglycerides in skeletal muscle 
(Romijn, Coyle, Sidossis, Gastaldelli, Horowitz, Endert & Wolfe, 1993). Therefore, FATMAX exercise, as an 
intervention, was included in the present study to facilitate fat oxidation and subsequently improve cardio-metabolic 
function. Perez-Martin et al. (2001) conducted a study comparing substrate utilisation between healthy obese and 
normal-weight participants during a FATMAX determination. An earlier shift to CHO oxidation and significantly 
lower maximal fat oxidation rates (MFO) were observed with obese participants compared to normal-weight 
indicating metabolic inflexibility amongst the obese cohort (Perez-Martin et al., 2001). However, in healthy 
participants Robinson, Hattersley, Frost, Chambers, and Wallis (2015) demonstrated a significant positive 
correlation between MFO and both 24-hour fat oxidation and insulin sensitivity. Furthermore, in obese yet 
metabolically healthy participants, FATMAX training elicited a 44% increase in fat oxidation rates and 27% 
increase in insulin sensitivity index (Venables & Jeukendrup, 2008). A meta-analysis of FATMAX training in 
obese, Metabolic Syndrome and Type 2 diabetic patients confirmed a shift of fat oxidation to higher exercise 
intensities and reductions in body weight, fat mass, waist circumference and cholesterol, thus advocating its use to 
improve health (Romain et al., 2012). Overall, these findings suggest FATMAX exercise encourages enhancements 
in fat oxidation rate leading to improved body composition, cholesterol and insulin sensitivity (Brun, Romain, & 
Mercier, 2011). 
Consequently, the purpose of specifically incorporating aerobic FATMAX exercise in the present study were 
twofold. Firstly, an individualised approach to achieve maximal fat oxidation rates during moderate-intensity 
exercise has been suggested as the best method to reduce glycated haemoglobin (HbA1c), insulin-dependent glucose, 
fat mass and total cholesterol (Brun et al., 2011). Secondly, it is an appropriate methodological test to measure the 
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effects of an intervention on fat oxidation rates during exercise and when combined with a potential calorie 
restrictive mimetic (CRM), such as MTCJ, may induce additional improvements on cardio-metabolic pathways and 
therefore overall health (Besnier et al., 2015). 
Rationale for the present study is based on previous work demonstrating the benefits of anthocyanin 
supplementation on fat oxidation rates during exercise (Cook, Myers, Gault, Edwards, & Willems, 2017; Cook, 
Myers, Blacker, & Willems, 2015) and the positive results regarding the effects of tart cherry supplementation 
against cardio-metabolic dysfunction in rodents (Seymour et al., 2009; Seymour et al., 2008) and humans (Ataie-
Jafari, 2008; Keane et al., 2016a; Keane et al., 2016b; Martin et al., 2010). However, to date, no research has 
explored the cardio-metabolic responses to tart cherry supplementation and exercise in tandem, thus healthy 
participants were recruited to assess for any adverse effects prior to investigating responses in clinical populations. 
Subsequently, this study set out to examine the physiological responses of MTCJ supplementation with FATMAX 
exercise on fat oxidation rates, body composition and cardio-metabolic markers in healthy participants. It was 
hypothesised that MTCJ supplementation would augment fat oxidation rates at rest and during exercise, thus 
proving more efficacious at improving body composition, functional and in sera cardio-metabolic markers than 
previous research conducted with tart (Lynn et al., 2014; Martin et al., 2010) and sweet (Kelley, Rasooly, Jacob, 
Kader, & Mackey, 2006) cherry supplementation at rest in healthy participants. 
 
Methods 
Participants 
Eleven (7 males and 4 females) healthy, recreationally active (150 minutes moderate-intensity aerobic exercise per 
week), participants (mean ± SD age 30 ± 10 years, height 1.76 ± 0.09 m, body mass 76.42 ± 13.19 kg, BMI 24.43 ± 
3.23 kg.m-2, V̇O2peak 35.87 ± 4.78 mL.kg-1.min-1) volunteered for the study. All participants were non-smokers, BMI 
<30, injury-free and not diagnosed with any cardio-metabolic or renal diseases at the time of testing but had a family 
history of cardio-metabolic disease. Participants were instructed to cease consumption of any other supplementation 
two weeks before and for the duration of the study. All participants provided written informed consent to participate 
in the study and completed health screen questionnaires before the study commenced. Ethical approval was obtained 
from the University of Hertfordshire Health and Human Sciences Ethics Committee and the study’s experimental 
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procedures followed the principles outlined in the 1964 Declaration of Helsinki. The study was registered as a 
clinical trial on clinicaltrials.gov (NCT02999256). 
As this was the first study to examine fat oxidation with cherries, it was difficult to confidently predict a sample size 
using power analyses. Previous studies that had researched the effects of fat oxidation (Cook, Myers, Blacker, & 
Willems, 2015; Roberts, Roberts, Tarpey, Weekes, & Thomas, 2015) or cherry supplementation (Bell, McHugh, 
Stevenson, & Howatson, 2014a; Bell et al., 2014b; Bowtell et al., 2011) had a total sample size between 10-16 
participants.  
Procedures 
Research Design 
This study utilised a single-blind (blinded to participants), placebo-controlled, randomised, counterbalanced design, 
where each participant acted as their own control. Participants were required to complete two conditions over 10 
weeks, differing only in supplementation, Montmorency tart cherry juice (MTCJ) and placebo (PLA). Participants 
were randomised to start consumption of either MTCJ or PLA first (6 received PLA first), followed by a 14-day 
washout period (Cook et al., 2015; Howatson et al., 2012; Keane et al., 2016a; Keane et al., 2016b) and then 
consumption of the opposite supplement to the first condition. 
Both conditions were identical in terms of design and testing procedures and comprised of 5 sessions each, with 
sessions lasting approximately 2.5 hours. Figure 1 shows a timeline for testing sessions and the supplementation 
period. ***Figure 1 near here*** 
Baseline measurements were obtained during the first FATMAX/V̇O2max session in the first condition. Other than 
blood sampling and the type of exercise itself, all other testing procedures pre- and post-exercise were identical 
across each session. Blood sampling was conducted pre- and post-exercise to ascertain the acute differences induced 
by one-hour of FATMAX exercise and pre-, mid- and post-supplementation to assess the longer-term effects of 
supplementation on cardio-metabolic biomarkers, within and between conditions. 
Dietary and Exercise Guidelines 
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Participants were instructed to refrain from consuming water and conducting vigorous exercise 3 and 24 hours 
before each testing session, respectively. All participants arrived at the laboratory between 7 – 10am, after an 
overnight fast of a minimum of 10 hours, to account for circadian variation (Bell et al., 2014b). Participants were 
instructed to drink fluids ad libitum and maintain their habitual polyphenol intake, particularly anthocyanins, as 
opposed to complete restriction throughout the study. This was to ensure that the polyphenols provided by MTCJ 
were supplementary to the existing habitual polyphenol intake of each participant representing normal daily activity 
and therefore upholding ecological validity (Meyer, Gassler, & Kindermann, 2007).  
Total energy, macronutrient and polyphenol intake was assessed through food diaries which were completed three 
days prior to each session. In addition to replicating their 3-day diary before each testing session, a standardised 
menu for the final 24-hours of the three-day period, was provided to each participant based on their healthy 
spontaneous habitual diet to reduce day-to-day intra-individual variability in fat oxidation (Roberts et al., 2015). 
Standardisation of macronutrients was set at 15% protein, 55% carbohydrate (CHO) and 30% fat of energy intake 
(Ben Ounis et al., 2009; Melanson et al., 2002) with 20% of the three-day average for habitual energy intake added 
to account for underreporting dietary consumption with food diaries (Black et al., 1993; Mertz et al., 1991). All 
participants reported 100% adherence when food diaries were assessed using dietary analysis software (Dietplan 7.0, 
Forestfield Software Ltd, West Sussex, UK) for percentage contributions of macronutrients to total energy intake, 
total polyphenols and anthocyanins.  
Supplementation 
The supplementation period lasted 20 days, similar to Roberts et al. (2015), where participants ceased consumption 
following the 20th day and during the washout period. The experimental condition included supplementation with 
MTCJ (Volume: 30 mL, Energy: 102 kcal, Carbohydrates: 24.50 g of which Sugars: 17.90 g, Protein: 1.10 g and 
Fat: 0 g) whilst the control involved supplementation of an energy matched placebo (Volume: 30 mL, Energy: 102 
kcal, Carbohydrates: 25.35 g of which Sugars: 25.32 g, Protein: 0.03 g and Fat: 0 g). The MTCJ was made with 30 
mL Montmorency tart cherry concentrate (Cherry Active, Active Edge Ltd, Hanworth, UK) and 100 mL water. 
Placebo composition consisted of 30 mL commercially available fruit-flavoured cordial (Cherries and Berries, 
Morrisons, Bradford, UK), with anthocyanins used only for colouring and negligible antioxidant content, mixed 
with 100 mL water. In order to match placebo for energy, taste and visual appearance, a flavourless carbohydrate 
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(Maltodextrin, My Protein Ltd, Northwich, UK), citric acid (100% Pure Citric Acid, VB and Sons, UK) and black 
food colouring (Morrisons, Bradford, UK) were added, respectively. Participants consumed two 130 mL servings 
per day, once in the morning immediately before breakfast, then again in the evening before dinner (Bell, Stevenson, 
Davison, & Howatson, 2016; Bell et al., 2014b). Due to fasting restrictions on testing days, participants delayed 
consumption of the morning serving until lunchtime. Each 30 mL serving of Montmorency tart cherry concentrate 
provided juice from approximately 90-110 whole Montmorency tart cherries with a total anthocyanin content of 270 
mg (9 mg.mL-1) (Howatson et al., 2012). 
Testing Protocol 
All testing sessions were conducted in a temperature-controlled laboratory kept between 21-24ºC and 38-45% 
relative humidity (dry-bulb) (AWS888N, Oregon Scientific, USA). 
During all testing sessions, stature (Seca 217 Stadiometer, Seca, Hamburg, Germany), body mass (Seca 799, 
Germany) and waist circumference (Seca 201, Germany) were measured initially, immediately followed by 
segmental body composition analysis (Body Composition Analyser BC-418, Tanita, Japan) via bioelectrical 
impedance. Body composition was measured according to the manufacturer’s guidelines and specific pre-
measurement conditions to reduce variability between measurements. Pilot work showed test-retest intra-individual 
variability (measurements taken in the morning from 5 participants according to the timeline of the study) of the 
body composition analyser to have coefficients of variation of 2.06% for percentage body fat and 1.91% for fat 
mass. Participants were not on any weight loss or weight gain regimen during this period. 
After 10 minutes’ rest, resting heart rate (HR) (Polar T31c and FT1, Polar Electro Oy, Finland) and blood pressure 
(BP) (Omron MX3, Omron, Japan) were obtained followed by resting metabolic rate (RMR). Pre-exercise blood 
sampling was then performed followed by post-exercise blood sampling during the one-hour sub-maximal sessions 
only. Heart rate and BP were measured after post-exercise blood sampling, approximately 5-8 minutes after the 
cessation of exercise (Figure 2A and 2B). ***Figure 2A and 2B near here*** 
Exercise Protocols 
 
During the first and fourth testing sessions of each condition, participants conducted FATMAX and maximal 
oxygen uptake (V̇O2max) tests.  
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The FATMAX (expressed as % of V̇O2peak) determination protocol, adapted from Achten, Gleeson, and 
Jeukendrup (2002) and Alkhatib, Seijo, Larumbe, and Naclerio (2015), required participants to cycle on an 
electromagnetically braked cycle ergometer (Excalibur, Lode, Groningen, The Netherlands) at 70 rev.min-1 at an 
initial intensity of 30W with increments of 10W every 3 minutes. The test was terminated once respiratory exchange 
ratio (RER) exceeded 1 for a continuous period of 30 seconds (Croci et al., 2014).  
The V̇O2max test was performed 15 minutes following the FATMAX test. Due to the low-intensity nature of the 
FATMAX test, 15 minutes provided sufficient recovery time before the V̇O2max test. The protocol for determination 
of V̇O2max consisted of cycling at 70-80 rev.min-1, at an initial intensity of 100W with wattage increasing by 20W 
every minute until volitional exhaustion. The test was terminated according to BASES Sport and Exercise 
Physiology testing guidelines (Winter, 2006). 
Heart rate and differentiated (overall and legs) ratings of perceived exertion (RPE) on a 6-20 scale (Borg, 1973) 
were recorded 15 seconds before the end of each stage for FATMAX and V̇O2max tests. RPE was also measured 
every 5 minutes during the one-hour sub-maximal exercise. 
FATMAX Analysis 
FATMAX was determined through visual inspection of the fat oxidation curve generated from the incremental sub-
maximal test and confirmed by identifying the highest fat oxidation rate for the final minute of each stage calculated 
from a 15 second rolling average of each 3 minute stage. The corresponding intensity (power output, W) at the peak 
of this curve was deemed to be FATMAX and was implemented during the one-hour sub-maximal exercise.  
The second V̇O2max and FATMAX tests were used to assess changes in fitness status (MacRae & Mefferd, 2006) 
and any differences in FATMAX which may have occurred due to the previous exercise sessions and 
supplementation. FATMAX was adjusted to the new exercise intensity for the post-supplementation one-hour sub-
maximal exercise if the change in FATMAX was greater than a pre-determined threshold (>6%).  
Measures and Equipment 
Blood Pressure and Heart Rate 
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Systolic (SBP) and diastolic (DBP) blood pressure was monitored pre- and post-exercise during all testing sessions 
where four measurements were recorded in an upright seated position, with an average of the final three being taken 
as BP (Cook et al., 2015). Resting HR was also recorded in the same anatomical position.  
Resting Metabolic Rate 
RMR, resting energy expenditure, substrate oxidation rates and RER were measured pre-exercise, based on an open-
circuit indirect calorimetry system (GEM Nutrition Ltd, Cheshire, UK). Participants lay supine for 30 minutes with 
data averaged for the final 20 minutes only, to achieve steady-state and account for any initial short-term variances 
in respiration (Kelly, King, Goerlach, & Nimmo, 2013). A ventilated hood was placed over the head with a flexible 
plastic seal around the neck and shoulders to prevent air inside and outside the hood from mixing. Participants 
remained silent and lay as still as possible, whilst music was played to prevent sleeping.  
Respiratory Gas Analysis 
Real-time breath-by-breath gaseous exchange data (Metalyzer 3B, Cortex Biophysik, Leipzig, Germany) of V̇O2 
(L.min-1), V̇CO2 (L.min-1) and RER were recorded during all exercise tests. Consequently, indirect calorimetry was 
used to calculate EE (kJ.min-1) and substrate oxidation rates (g.min-1) using stoichiometric equations, assuming 
negligible protein oxidation, specifically developed for exercise intensities between 40-50% V̇O2peak, as shown 
below (Jeukendrup & Wallis, 2005).  
Fat Oxidation Rate = (1.695˙V̇O2) - (1.701˙V̇CO2) 
CHO Oxidation Rate = (4.344˙V̇CO2) - (3.061˙V̇O2) 
Energy Expenditure = [(0.575˙V̇CO2) - (4.435˙V̇O2)] 
Exported data was analysed only from the final 50 minutes of all one-hour sub-maximal tests to ensure participants 
reached steady-state. Data was averaged for every 15 second period during the entire 50 minutes of exercise.  
Blood Sampling 
Venous blood, was sampled pre- and post-exercise, using the butterfly method (BD Vacutainer Safety-Lok Blood 
Collection Set 21G with Luer Adapter, Becton Dickinson and Co., Oxford, UK) from veins located in the 
antecubital fossa region, into one lithium heparin tube (4 mL) and one serum separator tube (4 mL) (BD Vacutainer, 
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Becton Dickinson and Co., Oxford, UK). Tubes were centrifuged at 4000 rev.min-1, 4ºC for 10 minutes (Sorvall ST 
8R, Thermo Fisher Scientific, USA). Serum and plasma supernatants were aliquoted and stored at -80ºC for later 
analysis. Blood samples were obtained from 10 participants, as one subject was uncomfortable with the 
venepuncture method. 
Biochemical Analysis 
Plasma Volume Change 
Whole blood from lithium heparin tubes, was analysed for haemoglobin (HemoCue Hb 201+ Reader, Sweden) and 
haematocrit to calculate plasma volume change (PVC). Haematocrit was analysed by pipetting 60µL of whole blood 
into micro-haematocrit capillary tubes (Hawksley, Lancing, Sussex, UK). Tubes were then centrifuged 
(Haematospin 1300, Hawksley, Lancing, Sussex, UK) at 1300 rev.min-1 for 3 minutes. Percentage packed cell 
volume was determined from a slide reader (Micro Haematocrit Tube Reader, Hawksley, Lancing, Sussex, UK). 
Assay results were corrected for PVC as a result of exercise-induced changes in haemoconcentration (Allgrove, 
Farrell, Gleeson, Williamson, & Cooper, 2011) by the equation shown below. 
Corrected Assay Results = %PVC × Measured Post-Exercise Assay Value 
PVC was determined using the method and equations of Dill and Costill (1974) by means of comparing the pre- and 
post-exercise haemoglobin and haematocrit values. 
Glucose 
Pre- and post-exercise serum samples were assessed for glucose (range 0.5-50 mmol.L-1, CV ≤ 1.5%) (Biosen C-
Line, EKF Diagnostics, Cardiff, UK) in duplicates.  
Total Antioxidant Status Assay 
Total antioxidant capacity within serum samples was assessed in duplicates according to the manufacturers 
guidelines using the total antioxidant status (Total Antioxidant Status NX2332, Randox Laboratories Ltd, Antrim, 
UK) colorimetric assay on a semi-automated spectrophotometer (RX Monza, Randox). Intra-assay CV was 3.49%. 
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Lipid Assays 
Serum lipids were determined in duplicates using commercially available colorimetric assays on a semi-automated 
spectrophotometer, according to manufacturer’s guidelines. Triglyceride (Triglycerides TR210, Randox) values 
were corrected for free glycerol by subtracting 0.11 mmol.L-1 (Stinshoff et al., 1977), according to the 
manufacturer’s guidelines. Intra-assay CV for triglycerides, total cholesterol and HDL were 4.96%, 1.99% and 
4.66%, respectively. The ratio between total cholesterol and HDL was also determined. LDL was determined 
indirectly using the formula below (Ahmadi, Boroumand, Gohari-Moghaddam, Tajik, & Dibaj, 2008). 
LDL (mmol.L-1) = (
Total Cholesterol
1.19
) + (
Triglycerides
0.81
) - (
HDL
1.1
) - 0.98 
Data Analysis 
Statistical analysis was performed using SPSS v22.0 (IBM, Chicago, USA) where data are reported as means ±SD. 
Data normality was checked using a Shapiro-Wilk test. Greenhouse-Geisser correction was applied upon violation 
of Mauchly’s test of sphericity for analyses of variance (ANOVA). Statistical significance was set at P < 0.05.  
A within-group 3-way, 2 x 3 x 2, condition (MTCJ vs PLA), time (pre-, mid-, post-supplementation), exercise (pre- 
and post-exercise), repeated-measures ANOVA with post-hoc Bonferroni’s adjustment, measured differences of 
body mass, BMI, HR, BP, glucose, TAS, triglycerides, total cholesterol, HDL, total cholesterol:HDL, haematocrit 
and haemoglobin. Waist circumference, body composition and resting EE, RER, fat and CHO oxidation were 
analysed using a 2-way, 2 x 3 (condition x time) repeated-measures ANOVA design with post-hoc Bonferroni’s 
adjustment. A paired-samples t-test was used to identify differences between individual data points within 
conditions and between conditions for the corresponding time point. 
Parameters measured during the FATMAX and V̇O2max tests, including MFO (maximal fat oxidation) and power 
output at FATMAX, FATMAX (% of V̇O2peak), RER at FATMAX, percentage of maximal HR (%HRmax) at 
FATMAX and V̇O2peak were analysed using a 2 x 2 (condition x time) repeated-measures ANOVA. A paired 
samples t-test was used to identify differences between conditions for only the first and second FATMAX tests. 
Variables measured during the one-hour sub-maximal exercise at FATMAX including, RER, HR, RPE (overall), 
RPE (legs), EE, CHO oxidation, fat oxidation and percentage contribution of fat and CHO to total EE, were 
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analysed using a 2 x 3 (condition x time) repeated-measures ANOVA with post-hoc Bonferroni’s adjustment, when 
averaged for the final 50 minutes.  
Partial Eta-Squared ( 2
partial ) was used to report effect sizes for ANOVAs where effects were classified as small 
(0.01-0.08), moderate (0.09-0.25) and large (>0.25) (Cohen, 1988). Cohen’s d effect size was used for paired-
samples t-test where effects were classified as no effect (0-0.1), small (0.2-0.4), moderate (0.5-0.7) and high (≥0.8) 
(Cohen, 1988). 
In order to determine whether independent variables could explain the variance observed for MFO, bivariate 
correlations were conducted between MFO values obtained during the final minute of the stage corresponding to 
FATMAX at baseline and independent variables affecting FATMAX, including age, anthropometrics, body 
composition, dietary intake and V̇O2peak. No significant correlations (P>0.05) were found for any independent 
variables, thus regression analysis was not performed. 
Results 
Exercise Results 
One-hour Sub-Maximal Cycling Tests 
No significant interactions or main effects for condition and time (P>0.05) were observed for mean EE, percentage 
contributions of fat and CHO to EE, V̇O2 and V̇CO2, HR, overall RPE, legs RPE and serum glucose during one-hour 
cycling at individual FATMAX suggesting exercise intensities and physiological responses were similar between 
conditions over the supplementation period (Table 1). ***Table 1 near here*** 
Mean fat oxidation rates during the final 50 minutes of the one-hour cycling exercise at individual FATMAX were 
not significantly different between conditions (PLA: 0.25 ± 0.10 g.min-1 and MTCJ: 0.26 ± 0.09 g.min-1; F(1, 10) = 
0.35; P = 0.567, 2
partial = 0.034), time (Pre-Supplementation: 0.25 ± 0.09 g.min
-1, Mid-Supplementation: 0.27 ± 0.08 
g.min-1, Post-Supplementation: 0.25 ± 0.11 g.min-1; F(2, 20) = 1.22; P = 0.318,
2
partial = 0.108) or the interaction 
between condition and time (F(2, 20) = 0.273; P = 0.764,
2
partial = 0.027) (Figure 3). ***Figure 3 near here*** 
There were also no main effects (P>0.05) for condition, time or the interaction for mean CHO oxidation rates.  
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A significant main effect for time (Pre-Supplementation: 0.88 ± 0.04, Mid-Supplementation: 0.87 ± 0.04, Post-
Supplementation: 0.89 ± 0.04; F(2, 20) = 4.14; P = 0.031,
2
partial = 0.293) was detected for mean RER but not between 
conditions or the interaction (P>0.05). Post-hoc analysis identified a trend towards significance between mid-
supplementation and post-supplementation (P = 0.070). 
FATMAX and V̇O2max Determination Tests 
No significant differences between conditions (PLA: 0.26 ± 0.05 g.min-1 and MTCJ: 0.23 ± 0.04 g.min-1; F(1, 10) = 
2.79; P = 0.126, 2
partial = 0.22) or time (Test 1: 0.25 ± 0.08 g.min
-1 and Test 2: 0.25 ± 0.10 g.min-1; F(1,10) = 0.06; P 
= 0.807, 2
partial = 0.01) were found for MFO during the FATMAX determination tests. A tendency (t(10) = 2.21; P 
= 0.052, d = 0.59) towards significance was observed between conditions for MFO during the second FATMAX 
test (PLA: 0.28 ± 0.12 g.min-1 and MTCJ: 0.22 ± 0.08 g.min-1). 
No main effects (P>0.05) for condition, time or interaction were detected for FATMAX (%V̇O2peak) (Test 1 – 
PLA: 42.77 ± 8.69% and MTCJ: 45.94 ± 9.28%, Test 2 – PLA: 45.28 ± 12.07% and MTCJ: 47.91 ± 11.52%), MFO 
(Test 1 – PLA: 0.25 ± 0.08 g.min-1 and MTCJ: 0.24 ± 0.08 g.min-1, Test 2 – PLA: 0.28 ± 0.12 g.min-1 and MTCJ: 
0.22 ± 0.08 g.min-1), RER at FATMAX (Test 1 – PLA: 0.87 ± 0.04 and MTCJ: 0.88 ± 0.04, Test 2 – PLA: 0.87 ± 
0.03 and MTCJ: 0.90 ± 0.03), %HRmax at FATMAX (Test 1 – PLA: 60.27 ± 9.59% and MTCJ: 62.58 ± 7.38%, Test 
2 – PLA: 59.84 ± 10.43% and MTCJ: 63.04 ± 8.38%), power output at FATMAX (Test 1 – PLA: 66 ± 20 W and 
MTCJ: 72 ± 18 W, Test 2 – PLA: 70 ± 19 W and MTCJ: 78 ± 18 W) and V̇O2peak (Test 1 – PLA: 36.10 ± 5.17 
mL.kg-1.min-1 and MTCJ: 36.33 ± 5.34 mL.kg-1.min-1, Test 2 – PLA: 37.07 ± 5.77 mL.kg-1.min-1 and MTCJ: 36.94 ± 
5.89 mL.kg-1.min-1). Values tended to be greater with MTCJ (F(1,10) = 3.65; P = 0.085, 
2
partial = 0.27) for RER at 
FATMAX, particularly during the second test (0.90 ± 0.03) compared to the first test (0.88 ± 0.04) (t(10) = -2.04; P = 
0.068, d = 0.63). RER at FATMAX was significantly greater (t(10) = -2.77; P = 0.020, d = 1.1) during the second test 
with MTCJ (0.90 ± 0.03) compared to PLA (0.87 ± 0.03). 
Paired-samples t-test between conditions did not outline any significant differences (t(10) = -2.04; P = 0.256, d = 
0.63) for the shift in wattage for FATMAX, where 3 participants increased wattage with PLA whilst 4 participants 
increased with MTCJ. Thus, the shift in wattage between conditions was considered negligible and not a limitation 
of the research. 
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Anthropometric and Functional Variables 
No interactions or main effects for condition and time were detected for anthropometric measurements in Table 2 
(P>0.05).  However, there was a tendency towards significantly lower percentage body fat (t(10) = 1.887; P = 0.08, d 
= 0.05) and fat mass (t(10) = 1.903; P = 0.08, d = 0.05) values pre- to post-supplementation with PLA compared to no 
difference with MTCJ for percentage body fat (t(10) = -0.841; P = 0.42, d = 0.02) and fat mass (t(10) = -1.386; P = 
0.196,  d = 0.04). 
No interactions or main effects for condition, time and exercise (P>0.05) were obtained for functional variables 
presented in Table 2, apart from a main effect of exercise for HR (F(1,10) = 25.493; P < 0.001, 
2
partial = 0.718), as 
expected. 
The change in resting EE from the mid- to post-supplementation trial was significantly different between conditions 
(t(10) = -2.602; P = 0.026, d = 0.86) suggesting different responses during days 10-20 of supplementation. A 
tendency towards significance was detected with MTCJ where resting CHO oxidation increased from mid- to post-
supplementation but not with PLA (t(10) = -2.213; P = 0.051, d = 0.77). 
*** Table 2 near here*** 
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Glucose and TAS Biomarkers 
No significant interactions or main effects for condition, time and exercise were detected for glucose (P>0.05). 
A main effect for time (F(2, 18) = 11.137; P = 0.001, 
2
partial = 0.55) and a significant interaction (F(1, 9) = 19.122; P = 
0.002, 2
partial = 0.68) between condition and exercise were detected for TAS (Figure 4). Post-hoc analysis revealed 
significantly lower concentrations post-supplementation compared to mid-supplementation. There was also a tendency 
towards significance for the interaction between time and exercise (F(2, 18) = 3.466; P = 0.053, 
2
partial = 0.28).  
Pre-exercise TAS with MTCJ was significantly lower post-supplementation (1.18 ± 0.02 mmol.L-1; 98.92% of baseline) 
compared to mid-supplementation (1.33 ± 0.05 mmol.L-1; 111.93% of baseline) by 11.45%. In comparison, values were 
statistically similar with PLA (t(9) = 1.464; P = 0.177, d = 0.47) (Table 3). There was a tendency towards significance 
(t(9) = -1.998; P = 0.077, d = 0.71) for the difference between pre-supplementation (1.17 ± 0.03 mmol.L-1; 101.26% of 
baseline) and mid-supplementation (1.33 ± 0.05 mmol.L-1; 111.93% of baseline) values prior to exercise with MTCJ, 
but not for PLA (t(9) = -0.556; P = 0.585, d = 0.24). After the onset of supplementation, the change in TAS during one-
hour FATMAX exercise was significantly different (t(19) = 2.291; P = 0.034, d = 0.64), where an average increase of 
1.75% was seen with MTCJ and a decrease of 5.17% with PLA. ***Figure 4 near here*** 
Lipid Biomarkers 
No significant interactions or main effects for condition, time and exercise were detected for triglycerides and LDL 
(P>0.05). 
A main effect for time only was found for HDL (F(1.3, 11.703)  = 7.098; P = 0.016,
2
partial = 0.441). Post-hoc analysis 
showed post-supplementation concentrations were significantly lower than mid-supplementation (P < 0.001) (Figure 5). 
As with TAS, a significant (t(9) = 3.123; P = 0.012, d = 0.68) reduction in pre-exercise HDL concentrations was 
observed from mid-supplementation (1.84 ± 0.47 mmol.L-1; 114.48% of baseline) to post-supplementation (1.56 ± 0.34 
mmol.L-1; 98.62% of baseline) with MTCJ whereas no difference was found for PLA (t(9) = 0.719; P = 0.490, d = 0.15) 
(Table 3). ***Figure 5 near here*** 
Mean post-exercise values for total cholesterol (main effect for exercise: F(1, 9) = 8.951; P = 0.015, 
2
partial = 0.5) and 
total cholesterol:HDL ratio (main effect for exercise: F(1, 9) = 8.951; P = 0.015, 
2
partial = 0.5) were significantly lower 
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than pre-exercise values. In addition, both total cholesterol (F(1.23, 11.154) = 6.092; P = 0.026, 
2
partial = 0.404) and total 
cholesterol:HDL (F(2, 18) = 10.995; P = 0.001, 
2
partial = 0.55) demonstrated main effects for time, however no main 
effect for condition, or significant interactions were detected (P>0.05). 
***Table 3 near here***
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Discussion 
This was the first study in any population to combine exercise and tart cherry supplementation whilst examining 
cardio-metabolic biomarkers. The main findings of this study were that 20 days of MTCJ supplementation did 
not significantly increase fat oxidation rates at rest or during FATMAX exercise, nor did it alter waist 
circumference, body composition or cardio-metabolic biomarkers compared to PLA.  
The present study did not find significance between conditions for RER, EE, fat and CHO oxidation rates, 
contrasting previously reported results regarding the effect of dietary anthocyanin supplementation on substrate 
metabolism with exercise.  Cook et al. (2015) observed a 16% increase in fat oxidation with 7 days 
encapsulated, anthocyanin-rich, New Zealand blackcurrant extract (NZBE) supplementation compared to 
placebo during cycling exercise at 65% V̇O2max. Crucially, Cook et al. (2015) instructed participants to 
consume one NZBE capsule, containing 105 mg anthocyanins, 2 hours prior to commencing exercise thus 
coinciding peak bioavailability and concentrations of anthocyanins, secondary metabolites and phase II 
conjugates in plasma and target tissues with the time of measurement of substrate oxidation rates during 
exercise. This provides evidence that fat oxidation can be increased with short-term (7 days) and acute (2 hours 
before exercise) supplementation of dietary anthocyanins and highlights the importance of timing of 
consumption to maximise bioavailability and concentrations in plasma and target tissues. Subsequently, the 
inclusion of an overnight fast may explain why Montmorency tart cherry anthocyanins and its metabolites were 
not able to significantly augment fat oxidation rates.  
Differences in fat oxidation responses to anthocyanin supplementation may be explained by the different types 
of anthocyanins present compared to MTCJ. The main anthocyanins in NZBE (35-50% delphinidin-3-rutinoside 
and 5-20% delphinidin-3-glucoside) in NZBE are derived from the anthocyanidin, delphinidin (Cook et al., 
2017), whereas cyanidin based anthocyanins (cyanidin-3-glucosylrutinoside and cyanidin-3-rutinoside) 
comprise 93% of the total anthocyanin content in Montmorency tart cherries (Kirakosyan et al., 2009). It has 
been previously reported that delphinidin based anthocyanins provide more effective cardio-metabolic 
protection than cyanidin based anthocyanins (Overall, Bonney, Wilson, Beermann, Grace, Esposito, Lila & 
Komarnytsky, 2017). Additionally, cyanidin is less stable in the gastrointestinal environment, although it is not 
dependent on gut bacteria for metabolism or absorption whereas delphinidin is dependent on gut bacteria 
(Overall et al., 2017). Healthy individuals are expected to have greater diversity and concentrations of ‘good’ 
gut bacteria, acting to increase the bioavailability of anthocyanins and their metabolites (Fernandes, Faria, 
Calhau, de Freitas, & Mateus, 2014; Hidalgo et al., 2012). Since gut bacteria do not modulate cyanidin-based 
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anthocyanin metabolism and absorption, it is not surprising that cardio-metabolic markers or fat oxidation rates 
were not improved in the healthy participants from this study. 
It is feasible that consumption of a fruit extract (NZBE) in capsule form would not influence substrate oxidation 
rates to a greater extent than supplements in juice form (MTCJ) when ingested immediately before exercise, 
given the likely differences in macronutrient content and metabolism such as anthocyanin degradation and 
absorption rates. Perhaps this explains why Cook et al. (2015) were able to observe greater fat oxidation with 
NZBE. Cook et al. (2015) reported NZBE anthocyanins contributed 30.70% of fat to total EE during exercise, 
whilst MTCJ peaked during the mid-supplementation test at 24.06% and averaged 21.48% throughout the 
present study. Similar results were reported with the placebo, with the most likely explanation being the high 
carbohydrate content of the MTCJ and placebo drinks, compared to the capsules provided in the NZBE study 
which were completely devoid of carbohydrate. The significant increase in resting EE was facilitated by 
upregulation of CHO oxidation signifying that the higher CHO content of MTCJ did induce greater glycolytic 
flux from days 10-20 of supplementation. This provides an explanation for the lower MFO rates and percentage 
contributions of fat to total EE in the present study compared to Cook et al. (2015). The absorption of 
maltodextrin, present in the placebo, from the small intestine into systemic circulation, has not been proven to 
be different from pure glucose, therefore the magnitude and time course of the glycaemic and insulinaemic 
response are expected to be similar either at rest or during exercise (Hofman, van Buul, & Brouns, 2016). 
However, as MTCJ contained fructose and glucose the significant elevation in CHO oxidation, at rest with 
MTCJ during the final 10 days of supplementation is likely due to fructose accumulation. In support of these 
findings, co-ingestion of glucose and fructose as opposed to either alone has been shown to significantly 
increase CHO oxidation rates in healthy participants (Jentjens & Jeukendrup, 2005). 
The tendency towards significance for the 13.35% increase in TAS from pre-supplementation to mid-
supplementation with MTCJ, may explain the tendency for greater fat oxidation with MTCJ during one-hour 
FATMAX exercise between these time points. The increase in oxygen flux and therefore generation of ROS 
during exercise (Radak, Zhao, Koltai, Ohno, & Atalay, 2013), as a by-product of fatty acid oxidation at 
FATMAX, may have been mitigated by MTCJ antioxidants. These antioxidant may have retarded mitophagy 
and preserved mitochondrial function, thus enabling the continuation of fat oxidation (Montgomery & Turner, 
2015). The 12.76% decrease in TAS from mid-supplementation to post-supplementation prior to exercise 
suggests TAS does not increase linearly with further ingestion of MTCJ after 10 days but returns to baseline. As 
far as the authors are aware, this is the first study to demonstrate such an effect. Consequently, this may have 
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contributed to the different responses observed between conditions for HDL and resting EE during days 10-20 
of supplementation. Endogenously derived antioxidants are the primary contributors to the antioxidant balance, 
thus supplementation of exogenous antioxidants may inhibit synthesis of endogenous antioxidants in order to 
maintain a homeostatic balance (Poljsak, Suput, & Milisav, 2013). Thus, it is plausible that the synthesis of 
endogenous antioxidants was reduced during the final 10 days of exogenous antioxidant supplementation with 
MTCJ resulting in a net reduction of TAS. A potential increase in oxidative stress from mid- to post-
supplementation may have contributed to inefficient oxidative metabolism and thus greater resting EE (Frisard 
& Ravussin, 2006). These findings are supported by Timmers et al. (2011) who reported significantly lower 
basal EE due to improved mitochondrial function and therefore metabolic efficiency after 30 days resveratrol 
supplementation , a potent antioxidant, in healthy, obese humans. Furthermore, the reduced synthesis/uptake of 
antioxidants may be a defensive mechanism against an excessively elevated antioxidant balance which may 
affect hormetic responses. Such is the complexity of the interactions of free radicals, pro-oxidant species, 
antioxidants and the cellular mechanisms involved, that no one reason is liable to be responsible for this 
potential antioxidant effect. 
In relation to lipid responses, Ataie-Jafari et al. (2008) reported tart cherry juice significantly reduced total 
cholesterol and LDL, whilst Martin et al. (2010) reported a significant improvement in triglycerides and VLDL. 
In both studies, participants were found to be hyperlipidaemic for the specific variables in which a treatment 
effect was observed. Likewise, studies (Kelley et al., 2006; Lynn et al., 2014) reporting non-significant 
differences with the cherry treatment recruited healthy participants, therefore it is reasoned the lack of cardio-
metabolic dysregulation does not provide sufficient scope for a cherry intervention to further regulate cardio-
metabolic function at rest. Despite the addition of an exercise intervention, a similar reasoning can be applied to 
the present study, given the healthy baseline lipid concentrations presented by the participants in this study. This 
observation is further supported by findings presented in rodents susceptible to dyslipidaemia responding 
significantly better to cherry consumption than those without dyslipidaemia (Seymour et al., 2009; Seymour et 
al., 2008; Wu et al., 2006). The molecular mechanisms associated with these responses were suggested to be via 
increased mRNA transcription of peroxisome proliferator-activated receptor alpha (PPARα), peroxisome 
proliferator-activated receptor gamma (PPARγ) and hepatic activation of these isoforms by cherry anthocyanins 
(Seymour et al., 2009; Seymour et al., 2008). Thus enhancing skeletal muscle insulin sensitisation due to 
increased fat oxidation through sirtuin-1 mediated PPARα and peroxisome proliferator-activated receptor 
gamma coactivator 1-alpha (PGC-1α) activation (Huffman, 2010).  
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It is apparent accumulation of anthocyanins and their metabolites with long-term supplementation likely did not 
occur in the present study. This is likely due to the poor bioavailability, intestinal absorption and rapid 
elimination rates of anthocyanins (Manach, Scalbert, Morand, Remesy, & Jimenez, 2004).  Alternatively, it may 
be that the anthocyanin and secondary metabolite concentrations in target tissues reached a ceiling level below a 
physiologically relevant threshold concentration (Krga et al., 2016) to affect serum lipids, thus explaining pre-
exercise HDL responses to MTCJ consumption. A biphasic response was observed where a non-significant, yet 
clinically relevant, increase in HDL from pre- to mid-supplementation was followed by a significant decline 
from mid- to post-supplementation with MTCJ but not PLA. Based on data from epidemiological studies with 
middle-age and high-risk subjects, suggesting an increase of 0.026 mmol.L-1 could reduce the risk of coronary 
heart disease by 2% in males (Gordon et al., 1989), the change in HDL from pre- to mid-supplementation would 
result in a risk reduction of 12% with MTCJ. However, this finding should be interpreted with caution as the 
translation across to healthy subjects of both sexes and the lack of statistical and clinically significant 
improvements for other lipid profile markers with MTCJ, renders the increase in HDL less important. The 
decline from mid- to post-supplementation suggests that administering cherry interventions longer than 10 days 
does not maintain elevated HDL concentrations, but rather a return to baseline as supported by findings from 
Kelley et al. (2006), Ataie-Jafari et al. (2008), Martin et al. (2010) and Lynn et al. (2014). 
Given the variability in study design and supplementation strategy in the present and previous studies (Ataie-
Jafari, Hosseini, Karimi, & Pajouhi, 2008; Kelley et al., 2006; Lynn et al., 2014; Martin et al., 2010) it is 
possible to conclude that the length of supplementation, volume and concentration of juice are unlikely to be 
factors responsible for the equivocal results regarding lipids after cherry consumption. Rather, the initial 
physiological status of participants is thought to be more influential regarding the efficacy of a cherry 
intervention. 
Finally, limitations associated with this study include the overnight fast dietary restriction put in place to reduce 
intra- and inter-individual variability, but at the expense of upholding ecological validity. Secondly, previous 
research has shown improvements in body mass, fat mass and metabolic function required participants to 
exercise at FATMAX 2-4 times per week for 2-12 months (Brun et al., 2011). Thus, Montmorency tart cherry 
anthocyanins were not able to compound upon any cellular and molecular adaptations promoting fat oxidation 
which may have occurred with FATMAX training. Thirdly, the small sample size did not assist the ability to 
find significant differences with MTCJ as post-hoc power analysis suggested the study was underpowered. 
Additionally, due to the differences in viscosity of the placebo and MTCJ, 9 out of 11 participants correctly 
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identified which supplement they were provided when asked at the end of the study. Consequently, this may 
have contributed to the lack of significance between conditions as participants could manipulate their activity 
during the study. This highlights a limitation of juice concentrate as a form of supplementation and perhaps 
alternative forms such as capsules are preferable to uphold anonymity between conditions. 
Future work should attempt to elucidate the cellular and molecular mechanisms, including epigenetic changes, 
in humans to provide a basis upon which theories explaining the obtained responses can be either accepted or 
refuted. This would provide crucial information by which supplementation strategies can be altered to maximise 
the efficacy of MTCJ. Based on Cook et al. (2015) findings, it would be appropriate to suggest that any effect of 
anthocyanin supplementation on fat oxidation is short-term and provides a rationale to acutely supplement 
Montmorency tart cherry anthocyanins in future studies. The augmentation of fat oxidation with acute 
supplementation may then mitigate the development of cardio-metabolic symptoms in clinical populations such 
as those with Metabolic Syndrome.  
Conclusion 
This was the first study to examine the effect of cherry supplementation on fat oxidation rates at rest and during 
exercise. Findings showed that MTCJ did not significantly increase fat oxidation rates at rest or during 
FATMAX exercise. Additionally, secondary cardio-metabolic markers were also not significantly different with 
MTCJ supplementation, the primary reason being that this intervention does not indicate CRM properties in 
healthy participants. Consequently, it is unnecessary for healthy participants to supplement MTCJ to reduce 
body fat percentage and improve both functional and blood-based cardio-metabolic markers. Previous studies to 
report a significant response to cherry supplementation in animal (Seymour et al., 2009; Seymour et al., 2008; 
Wu et al., 2006) and human (Ataie-Jafari et al., 2008; Keane et al., 2016a; Keane et al., 2016b; Martin et al., 
2010) studies occurred when initial values were abnormal, thus further research is warranted in clinical 
populations. 
 
Conflicts of Interest 
Conflicts of interest: none. 
References 
Achten, J., Gleeson, M., & Jeukendrup, A. E. (2002). Determination of the exercise intensity that elicits 
maximal fat oxidation. Med Sci Sports Exerc, 34(1), 92-97.  
22 
 
Ahmadi, S. A., Boroumand, M. A., Gohari-Moghaddam, K., Tajik, P., & Dibaj, S. M. (2008). The impact of low 
serum triglyceride on LDL-cholesterol estimation. Arch Iran Med, 11(3), 318-321. doi: 
08113/aim.0014 
Alkhatib, A., Seijo, M., Larumbe, E., & Naclerio, F. (2015). Acute effectiveness of a "fat-loss" product on 
substrate utilization, perception of hunger, mood state and rate of perceived exertion at rest and during 
exercise. J Int Soc Sports Nutr, 12, 44. doi: 10.1186/s12970-015-0105-8 
Allgrove, J., Farrell, E., Gleeson, M., Williamson, G., & Cooper, K. (2011). Regular dark chocolate 
consumption's reduction of oxidative stress and increase of free-fatty-acid mobilization in response to 
prolonged cycling. Int J Sport Nutr Exerc Metab, 21(2), 113-123.  
Ataie-Jafari, A., Hosseini, S., Karimi, F., & Pajouhi, M. (2008). Effects of sour cherry juice on blood glucose 
and some cardiovascular risk factors improvements in diabetic women. Nutrition & Food Science, 
38(4), 355-360. doi: 10.1108/00346650810891414 
Bell, P. G., McHugh, M. P., Stevenson, E., & Howatson, G. (2014a). The role of cherries in exercise and health. 
Scand J Med Sci Sports, 24(3), 477-490. doi: 10.1111/sms.12085 
Bell, P. G., Walshe, I. H., Davison, G. W., Stevenson, E., & Howatson, G. (2014b). Montmorency cherries 
reduce the oxidative stress and inflammatory responses to repeated days high-intensity stochastic 
cycling. Nutrients, 6(2), 829-843. doi: 10.3390/nu6020829 
Bell, P. G., Stevenson, E., Davison, G. W., & Howatson, G. (2016). The Effects of Montmorency Tart Cherry 
Concentrate Supplementation on Recovery Following Prolonged, Intermittent Exercise. Nutrients, 8(7). 
doi: 10.3390/nu8070441 
Bell, P. G., Walshe, I. H., Davison, G. W., Stevenson, E. J., & Howatson, G. (2015). Recovery facilitation with 
Montmorency cherries following high-intensity, metabolically challenging exercise. Appl Physiol Nutr 
Metab, 40(4), 414-423. doi: 10.1139/apnm-2014-0244 
Ben Ounis, O., Elloumi, M., Amri, M., Trabelsi, Y., Lac, G., & Tabka, Z. (2009). Impact of training and 
hypocaloric diet on fat oxidation and body composition in obese adolescents. . Science and Sports, 
24(3), 178-185.  
Bertoia, M. L., Rimm, E. B., Mukamal, K. J., Hu, F. B., Willett, W. C., & Cassidy, A. (2016). Dietary flavonoid 
intake and weight maintenance: three prospective cohorts of 124,086 US men and women followed for 
up to 24 years. Bmj, 352, i17. doi: 10.1136/bmj.i17 
23 
 
Besnier, F., Lenclume, V., Gerardin, P., Fianu, A., Martinez, J., Naty, N., . . . Favier, F. (2015). Individualized 
Exercise Training at Maximal Fat Oxidation Combined with Fruit and Vegetable-Rich Diet in 
Overweight or Obese Women: The LIPOXmax-Reunion Randomized Controlled Trial. PLoS One, 
10(11), e0139246. doi: 10.1371/journal.pone.0139246 
Black, A. E., Prentice, A. M., Goldberg, G. R., Jebb, S. A., Bingham, S. A., Livingstone, M. B., & Coward, W. 
A. (1993). Measurements of total energy expenditure provide insights into the validity of dietary 
measurements of energy intake. J Am Diet Assoc, 93(5), 572-579.  
Borg, G. A. (1973). Perceived exertion: a note on "history" and methods. Med Sci Sports, 5(2), 90-93.  
Bowtell, J. L., Sumners, D. P., Dyer, A., Fox, P., & Mileva, K. N. (2011). Montmorency cherry juice reduces 
muscle damage caused by intensive strength exercise. Med Sci Sports Exerc, 43(8), 1544-1551. doi: 
10.1249/MSS.0b013e31820e5adc 
Brun, J. F., Romain, A. J., & Mercier, J. (2011). Maximal lipid oxidation during exercise (Lipox max): From 
physiological measurements to clinical applications. Facts and uncertainties. Science and Sports, 26(2), 
57-71.  
Cook, M. D., Myers, S. D., Blacker, S. D., & Willems, M. E. (2015). New Zealand blackcurrant extract 
improves cycling performance and fat oxidation in cyclists. Eur J Appl Physiol, 115(11), 2357-2365. 
doi: 10.1007/s00421-015-3215-8 
Croci, I., Hickman, I. J., Wood, R. E., Borrani, F., Macdonald, G. A., & Byrne, N. M. (2014). Fat oxidation over 
a range of exercise intensities: fitness versus fatness. Appl Physiol Nutr Metab, 39(12), 1352-1359. doi: 
10.1139/apnm-2014-0144 
Dill, D. B., & Costill, D. L. (1974). Calculation of percentage changes in volumes of blood, plasma, and red 
cells in dehydration. J Appl Physiol, 37(2), 247-248.  
Fernandes, I., Faria, A., Calhau, C., de Freitas, V., & Mateus, N. (2014). Bioavailability of anthocyanins and 
derivatives. Journal of Functional Foods, 7(Supplement C), 54-66. doi: 
https://doi.org/10.1016/j.jff.2013.05.010 
Frisard, M., & Ravussin, E. (2006). Energy metabolism and oxidative stress: impact on the metabolic syndrome 
and the aging process. Endocrine, 29(1), 27-32. doi: 10.1385/endo:29:1:27 
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., . . . Tyroler, H. A. 
(1989). High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American 
studies. Circulation, 79(1), 8-15.  
24 
 
Guo, H., & Ling, W. (2015). The update of anthocyanins on obesity and type 2 diabetes: experimental evidence 
and clinical perspectives. Rev Endocr Metab Disord, 16(1), 1-13. doi: 10.1007/s11154-014-9302-z 
He, J., & Giusti, M. M. (2010). Anthocyanins: natural colorants with health-promoting properties. Annu Rev 
Food Sci Technol, 1, 163-187. doi: 10.1146/annurev.food.080708.100754 
Hidalgo, M., Oruna-Concha, M. J., Kolida, S., Walton, G. E., Kallithraka, S., Spencer, J. P., & de Pascual-
Teresa, S. (2012). Metabolism of anthocyanins by human gut microflora and their influence on gut 
bacterial growth. Journal of Agricultural and Food Chemistry, 60(15), 3882-3890. doi: doi: 
10.1021/jf3002153 
Hofman, D. L., van Buul, V. J., & Brouns, F. J. (2016). Nutrition, Health, and Regulatory Aspects of Digestible 
Maltodextrins. Crit Rev Food Sci Nutr, 56(12), 2091-2100. doi: 10.1080/10408398.2014.940415 
Howatson, G., Bell, P. G., Tallent, J., Middleton, B., McHugh, M. P., & Ellis, J. (2012). Effect of tart cherry 
juice (Prunus cerasus) on melatonin levels and enhanced sleep quality. Eur J Nutr, 51(8), 909-916. doi: 
10.1007/s00394-011-0263-7 
Huffman, D. M. (2010). Exercise as a calorie restriction mimetic: implications for improving healthy aging and 
longevity. Interdiscip Top Gerontol, 37, 157-174. doi: 10.1159/000320000 
Jentjens, R. L., & Jeukendrup, A. E. (2005). High rates of exogenous carbohydrate oxidation from a mixture of 
glucose and fructose ingested during prolonged cycling exercise. Br J Nutr, 93(4), 485-492.  
Jeukendrup, A. E., & Wallis, G. A. (2005). Measurement of substrate oxidation during exercise by means of gas 
exchange measurements. Int J Sports Med, 26 Suppl 1, S28-37. doi: 10.1055/s-2004-830512 
Keane, K. M., George, T. W., Constantinou, C. L., Brown, M. A., Clifford, T., & Howatson, G. (2016a). Effects 
of Montmorency tart cherry (Prunus Cerasus L.) consumption on vascular function in men with early 
hypertension. 103(6), 1531-1539. doi: 10.3945/ajcn.115.123869 
Keane, K. M., Haskell-Ramsay, C. F., Veasey, R. C., & Howatson, G. (2016b). Montmorency Tart cherries 
(Prunus cerasus L.) modulate vascular function acutely, in the absence of improvement in cognitive 
performance. Am J Clin Nutr, 116(11), 1935-1944. doi: 10.3945/ajcn.115.123869 
10.1017/s0007114516004177 
Kelley, D. S., Rasooly, R., Jacob, R. A., Kader, A. A., & Mackey, B. E. (2006). Consumption of Bing sweet 
cherries lowers circulating concentrations of inflammation markers in healthy men and women. J Nutr, 
136(4), 981-986.  
25 
 
Kelly, B., King, J. A., Goerlach, J., & Nimmo, M. A. (2013). The impact of high-intensity intermittent exercise 
on resting metabolic rate in healthy males. Eur J Appl Physiol, 113(12), 3039-3047. doi: 
10.1007/s00421-013-2741-5 
Kirakosyan, A., Seymour, E. M., Llanes, D. E. U., Kaufman, P. B., & Bolling, S. F. (2009). Chemical profile 
and antioxidant capacities of tart cherry products. Food Chemistry, 115(1), 20-25.  
Kirakosyan, A., Seymour, E. M., Noon, K. R., Llanes, D. E. U., Kaufman, P. B., Warber, S. L., & Bolling, S. F. 
(2010). Interactions of antioxidants isolated from tart cherry (Prunus cerasus) fruits. Food Chemistry, 
122(1), 78-83.  
Krga, I., Monfoulet, L. E., Konic-Ristic, A., Mercier, S., Glibetic, M., Morand, C., & Milenkovic, D. (2016). 
Anthocyanins and their gut metabolites reduce the adhesion of monocyte to TNFalpha-activated 
endothelial cells at physiologically relevant concentrations. Arch Biochem Biophys, 599, 51-59. doi: 
10.1016/j.abb.2016.02.006 
Li, D., Wang, P., Luo, Y., Zhao, M., & Chen, F. (2017). Health benefits of anthocyanins and molecular 
mechanisms: Update from recent decade. Crit Rev Food Sci Nutr, 57(8), 1729-1741. doi: 
10.1080/10408398.2015.1030064 
Lynn, A., Mathew, S., Moore, C. T., Russell, J., Robinson, E., Soumpasi, V., & Barker, M. E. (2014). Effect of 
a tart cherry juice supplement on arterial stiffness and inflammation in healthy adults: a randomised 
controlled trial. Plant Foods Hum Nutr, 69(2), 122-127. doi: 10.1007/s11130-014-0409-x 
MacRae, H. S., & Mefferd, K. M. (2006). Dietary antioxidant supplementation combined with quercetin 
improves cycling time trial performance. Int J Sport Nutr Exerc Metab, 16(4), 405-419.  
Manach, C., Scalbert, A., Morand, C., Remesy, C., & Jimenez, L. (2004). Polyphenols: food sources and 
bioavailability. Am J Clin Nutr, 79(5), 727-747.  
Martin, K. R., Bopp, J., Neupane, S., & Vega-Lopez, S. (2010b). 100% Tart cherry juice reduces plasma 
triglycerides and CVD risk in overweight and obese subjects. The FASEB Journal, 24(1), 722-714.  
Melanson, E. L., Sharp, T. A., Seagle, H. M., Horton, T. J., Donahoo, W. T., Grunwald, G. K., . . . Hill, J. O. 
(2002). Effect of exercise intensity on 24-h energy expenditure and nutrient oxidation. J Appl Physiol 
(1985), 92(3), 1045-1052. doi: 10.1152/japplphysiol.00706.2001 
Mertz, W., Tsui, J. C., Judd, J. T., Reiser, S., Hallfrisch, J., Morris, E. R., . . . Lashley, E. (1991). What are 
people really eating? The relation between energy intake derived from estimated diet records and 
intake determined to maintain body weight. Am J Clin Nutr, 54(2), 291-295.  
26 
 
Meyer, T., Gassler, N., & Kindermann, W. (2007). Determination of "Fatmax"with 1 h cycling protocols of 
constant load. Appl Physiol Nutr Metab, 32(2), 249-256. doi: 10.1139/h06-108 
Montgomery, M. K., & Turner, N. (2015). Mitochondrial dysfunction and insulin resistance: an update. Endocr 
Connect, 4(1), R1-r15. doi: 10.1530/ec-14-0092 
Perez-Martin, A., Dumortier, M., Raynaud, E., Brun, J. F., Fedou, C., Bringer, J., & Mercier, J. (2001). Balance 
of substrate oxidation during submaximal exercise in lean and obese people. Diabetes Metab, 27(4 Pt 
1), 466-474.  
Poljsak, B., Suput, D., & Milisav, I. (2013). Achieving the balance between ROS and antioxidants: when to use 
the synthetic antioxidants. Oxid Med Cell Longev, 2013, 956792. doi: 10.1155/2013/956792 
Radak, Z., Zhao, Z., Koltai, E., Ohno, H., & Atalay, M. (2013). Oxygen consumption and usage during physical 
exercise: the balance between oxidative stress and ROS-dependent adaptive signaling. Antioxid Redox 
Signal, 18(10), 1208-1246. doi: 10.1089/ars.2011.4498 
Roberts, J. D., Roberts, M. G., Tarpey, M. D., Weekes, J. C., & Thomas, C. H. (2015). The effect of a 
decaffeinated green tea extract formula on fat oxidation, body composition and exercise performance. J 
Int Soc Sports Nutr, 12(1), 1. doi: 10.1186/s12970-014-0062-7 
Robinson, S. L., Hattersley, J., Frost, G. S., Chambers, E. S., & Wallis, G. A. (2015). Maximal fat oxidation 
during exercise is positively associated with 24-hour fat oxidation and insulin sensitivity in young, 
healthy men. J Appl Physiol (1985), 118(11), 1415-1422. doi: 10.1152/japplphysiol.00058.2015 
Romain, A. J., Carayol, M., Desplan, M., Fedou, C., Ninot, G., Mercier, J., . . . Brun, J. F. (2012). Physical 
activity targeted at maximal lipid oxidation: a meta-analysis. J Nutr Metab, 2012, 285395. doi: 
10.1155/2012/285395 
Seymour, E. M., Lewis, S. K., Urcuyo-Llanes, D. E., Tanone, II, Kirakosyan, A., Kaufman, P. B., & Bolling, S. 
F. (2009). Regular tart cherry intake alters abdominal adiposity, adipose gene transcription, and 
inflammation in obesity-prone rats fed a high fat diet. J Med Food, 12(5), 935-942. doi: 
10.1089/jmf.2008.0270 
Seymour, E. M., Singer, A. A., Kirakosyan, A., Urcuyo-Llanes, D. E., Kaufman, P. B., & Bolling, S. F. (2008). 
Altered hyperlipidemia, hepatic steatosis, and hepatic peroxisome proliferator-activated receptors in 
rats with intake of tart cherry. J Med Food, 11(2), 252-259. doi: 10.1089/jmf.2007.658 
Stinshoff, K., Weisshaar, D., Staehler, F., Hesse, D., Gruber, W., & Steier, E. (1977). Relation between 
concentrations of free glycerol and triglycerides in human sera. Clin Chem, 23(6), 1029-1032.  
27 
 
Stump, C. S., Henriksen, E. J., Wei, Y., & Sowers, J. R. (2006). The metabolic syndrome: role of skeletal 
muscle metabolism. Ann Med, 38(6), 389-402. doi: 10.1080/07853890600888413 
Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., Goossens, G. H., . . . Schrauwen, P. 
(2011). Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism 
and metabolic profile in obese humans. Cell Metab, 14(5), 612-622. doi: 10.1016/j.cmet.2011.10.002 
Venables, M. C., & Jeukendrup, A. E. (2008). Endurance training and obesity: effect on substrate metabolism 
and insulin sensitivity. Med Sci Sports Exerc, 40(3), 495-502. doi: 10.1249/MSS.0b013e31815f256f 
Vendrame, S., Del Bo, C., Ciappellano, S., Riso, P., & Klimis-Zacas, D. (2016). Berry Fruit Consumption and 
Metabolic Syndrome. Antioxidants (Basel), 5(4). doi: 10.3390/antiox5040034 
Winter, E. (2006). Sport and Exercise Physiology Testing Guidelines: Volume I - Sport Testing: Sport Testing. . 
London: Routledge. 
Wu, X., Beecher, G. R., Holden, J. M., Haytowitz, D. B., Gebhardt, S. E., & Prior, R. L. (2006). Concentrations 
of anthocyanins in common foods in the United States and estimation of normal consumption. J Agric 
Food Chem, 54(11), 4069-4075. doi: 10.1021/jf060300l 
Zheng, J., Zhou, Y., Li, S., Zhang, P., Zhou, T., Xu, D. P., & Li, H. B. (2017). Effects and Mechanisms of Fruit 
and Vegetable Juices on Cardiovascular Diseases. Int J Mol Sci, 18(3). doi: 10.3390/ijms18030555 
 
Figure Captions 
Fig 1. Schematic of testing protocol for each condition (MTCJ and PLA). 
Fig 2. Schematic of testing procedure during FATMAX and VO2max testing sessions (A) and during 1-hour 
sub-maximal exercise at individually determined FATMAX sessions (B). 
Fig 3. Mean (±SD) fat oxidation rates measured during final 50 minutes exercise at individual FATMAX for 
PLA and MTCJ. 
Fig 4. Mean (±SD) TAS concentrations presented at all measured time points for PLA and MTCJ. *Denotes 
significant difference between corresponding time point during post-supplementation for MTCJ. 
Fig 5. Mean (±SD) HDL concentrations presented at all measured time points for PLA and MTCJ. *Denotes 
significant difference between corresponding time point during post-supplementation for MTCJ. 
 
Table Captions 
Table 1. Mean (±SD) values of final 50 minutes for variables measured during one-hour exercise at individual 
FATMAX throughout the study duration for PLA and MTCJ. 
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Table 2. Mean (±SD) for anthropometric, body composition and resting functional variables obtained pre- 
and/or post-exercise in both conditions at baseline and during pre-, mid- and post-supplementation trials. 
Table 3. Mean (±SD) for all blood-based biomarkers measured for PLA and MTCJ during pre-, mid-, post-
supplementation, before and after one-hour FATMAX exercise. 
